Ingevity (NGVT) EBIT (2015 - 2026)

Ingevity (NGVT) has 12 years of EBIT data on file, last reported at $68.5 million in Q1 2026.

• Quarterly EBIT rose 12.11% year-over-year to $68.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $273.3 million (down 4.61% YoY) and the FY2025 annual result came in at $249.1 million, down 11.73% from the prior year.
• EBIT improved to $68.5 million in Q1 2026 per NGVT's latest filing, from $36.1 million in the prior quarter.
• Across five years, EBIT topped out at $111.2 million in Q3 2022 and bottomed at -$17.1 million in Q1 2024.
• The 5-year median for EBIT is $71.1 million (2023), against an average of $63.4 million.
• Peak annual rise in EBIT reached 901.59% in 2024, while the deepest fall reached 124.05% in 2024.
• Tracing NGVT's EBIT over 5 years: stood at $39.2 million in 2022, then plunged by 83.93% to $6.3 million in 2023, then surged by 901.59% to $63.1 million in 2024, then sank by 42.79% to $36.1 million in 2025, then soared by 89.75% to $68.5 million in 2026.
• Per Business Quant, the three latest NGVT EBIT figures stand at $68.5 million (Q1 2026), $36.1 million (Q4 2025), and $82.8 million (Q3 2025).

Peer Comparison